Patients Experiencing Early Virologic Failure on a Protease Inhibitor- or Nonnucleoside Reverse Transcriptase Inhibitor-Based Initial Regimen Containing a Thymidine Analogue and Lamivudine Can Be Successfully Treated With a Quadruple-Nucleoside Regimen

Journal article

Peer reviewed

Allan Rodriguez, Christina Hill-Zabala, Louis Sloan, Thomas Jefferson, Linda Yau, Maria Watson, David Irlbeck and Mark Shaefer

Journal of acquired immune deficiency syndromes (1999), Vol.41(1), pp.127-129

2006-01-01

PMID: 16340487

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1372 Lipodystrophy
Web Of Science research areas: Immunology; Infectious Diseases
ESI research areas: Immunology

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Patients Experiencing Early Virologic Failure on a Protease Inhibitor- or Nonnucleoside Reverse Transcriptase Inhibitor-Based Initial Regimen Containing a Thymidine Analogue and Lamivudine Can Be Successfully Treated With a Quadruple-Nucleoside Regimen
Creators: Allan Rodriguez - University of Miami, Miami, FL, †GlaxoSmithKline, Research, Triangle Park, NC, ‡North Texas IDC, Dallas, TX, §Health for Life, Little Rock, AR
Christina Hill-Zabala
Louis Sloan
Thomas Jefferson
Linda Yau
Maria Watson
David Irlbeck
Mark Shaefer
Publication Details: Journal of acquired immune deficiency syndromes (1999), Vol.41(1), pp.127-129
Publisher: Lippincott Williams & Wilkins, Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
Language: English
Resource Type: Journal article
PMID: 16340487
Record Identifier: 991031600827502976